SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?


To: J.F. who wrote (20907)12/12/2006 9:15:05 AM
From: ACAN  Read Replies (1) | Respond to of 23958
 
jf; TGEN and PPHM also in play on news and moving up PM



To: J.F. who wrote (20907)12/12/2006 9:16:25 AM
From: ACAN  Respond to of 23958
 
jf;

Peregrine Pharmaceuticals Reports Preclinical Data That Shows Bavituximab Equivalent Plus Docetaxel Reduces Growth of Human Prostate Tumors by 94 Percent
Tuesday December 12, 9:00 am ET